Cardio Edge
120 Capsules

Cholesterol Maintenance
Cardiovascular Health

Dietary supplements containing at least 400 mg. per serving of plant sterols, taken twice daily with meals for a daily total intake of at least 800mg. as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of Cardio-Edge supplies 400mg. of plant sterols.

Sytrinol™ - A unique and powerful ingredient for maintaining cholesterol health. The healthful effects of both bioflavonoids as well as tocotrienols have been recognized for years. Sytrinol provides a patented and well-researched combination of flavonoids derived from the peel of tangerines and tocotrienols derived palm. Within the peel of certain fruits, compounds belonging to a class of flavonoids called polymethoxylated flavones can be found. These compounds are similar in structure to flavones, but contain additional methyl groups on their ring structure, giving them the name polymethoxylated flavones – also known as PMFs. The primary PMFs present in Sytrinol are nobiletin and tangeretin. Science on PMFs dates back to the 1960s and covers both their antioxidant as well as their anti-inflammatory actions.

Specifically, with respect to cholesterol metabolism, PMFs have been shown to decrease apolipoprotein B, the structural protein needed for the synthesis of LDL-cholesterol. Nobiletin and tangeretin have also been shown to decrease diacylglycerol acetyl transferase, an enzyme in the liver involved in the synthesis of triglycerides. In addition to PMFs, Sytrinol contains tocotrienols derived from palm. Tocotrienols, a group of compounds belonging to the vitamin E family, have also been studied over the years for their ability to act as antioxidants and to help support cardiovascular health. Tocotrienols have been shown to inhibit HMG-CoA reductase, the hepatic enzyme responsible for the rate limiting step in the synthesis of cholesterol. Consequently, the combined action of the PMFs and tocotrienols contained in Sytrinol results in a powerful synergistic action to support cardiovascular health. This effect has been confirmed in both animal as well as human studies. In human clinical studies, Sytrinol given at a dose of 150 mg twice daily (daily dose of 300 mg) to hypercholesterolemic subjects for 4 weeks resulted in average reductions of total cholesterol by 20-24%, LDL-cholesterol by 19-22 %, and triglycerides by 24-28%. Additionally, the LDL/HDL ratio was significantly improved. Larger and longer follow up studies involving 120 hypercholesterolemic subjects supplemented for 12 weeks have yielded similar findings.

The information provided in this Supplement Section is of a general nature only and is not meant to replace the advice of your doctor. None of the information about the products on this site are intended to diagnose, treat, cure or prevent any disease. Please contact your healthcare provider for advice for your specific health or medical needs.